" class="no-js "lang="en-US"> Shao-Lee Lin - Medtech Alert
Thursday, March 28, 2024
Shao-Lee Lin

Shao-Lee Lin

About Shao-Lee Lin

As a physician, scientist, and biopharma leader, I have had the privilege of developing medicines to make a meaningful impact on patients’ lives. One critical realization through these efforts is that “all of us are better than any one of us.” This philosophy defines my leadership style; it impacts how I set aspirational goals, encourage others to reach higher, and harness the power of inclusion and diversity to fuel creative solutions. In doing so, I have seen the extraordinary contributions talented people can make while working together towards a unified goal.

Related Story

ACELYRIN, INC. Closes $250 Million Series B Financing and Announces Licensing of Izokibep, a Late-Stage IL-17A Inhibitor to Treat Inflammatory Diseases

November 16 2021

ACELYRIN, INC., an innovative clinical-stage biopharma company that identifies, acquires, and accelerates the development and […]